Cargando…

Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort study

INTRODUCTION: In 2013, the World Health Organization (WHO) recommended initiating combination ART (cART) in all adults with HIV and CD4+ lymphocyte counts (CD4) <500 cells/mm(3). In 2015, this was updated to recommend cART initiation in all patients with HIV, regardless of CD4 count. Implementati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crabtree‐Ramírez, Brenda E, Caro‐Vega, Yanink, Belaunzarán‐Zamudio, Pablo F, Shepherd, Bryan E, Rebeiro, Peter F, Veloso, Valdilea, Cortes, Claudia P, Padgett, Denis, Gotuzzo, Eduardo, Sierra‐Madero, Juan, McGowan, Catherine C, Person, Anna K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922020/ https://www.ncbi.nlm.nih.gov/pubmed/31855320 http://dx.doi.org/10.1002/jia2.25413

Ejemplares similares

Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors
por: Núñez, Isaac, et al.
Publicado: (2022)

Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study
por: Caro-Vega, Yanink, et al.
Publicado: (2022)

CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
por: Luz, Paula M., et al.
Publicado: (2015)

Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters
por: Crabtree-Ramírez, Brenda, et al.
Publicado: (2011)

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America
por: Caro-Vega, Yanink, et al.
Publicado: (2018)

Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America
por: Crabtree-Ramírez, Brenda, et al.
Publicado: (2016)

Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America
por: Belaunzaran-Zamudio, Pablo F., et al.
Publicado: (2020)

Monitoring of HIV treatment in seven countries in the WHO Region of the Americas
por: Belaunzarán-Zamudio, Pablo F, et al.
Publicado: (2015)

Is substance use associated with HIV cascade outcomes in Latin America?
por: De Boni, Raquel B., et al.
Publicado: (2018)

Use of Third Line Antiretroviral Therapy in Latin America
por: Cesar, Carina, et al.
Publicado: (2014)

The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead
por: Crabtree‐Ramírez, Brenda, et al.
Publicado: (2020)

Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression
por: Rebeiro, Peter F, et al.
Publicado: (2016)

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy
por: Crabtree-Ramirez, Brenda, et al.
Publicado: (2022)

Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America
por: Fink, Valeria I., et al.
Publicado: (2018)

Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America
por: Castilho, Jessica L, et al.
Publicado: (2021)

A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy
por: Wolff, Marcelo J., et al.
Publicado: (2017)

Interactive Data Visualization for HIV Cohorts: Leveraging Data Exchange Standards to Share and Reuse Research Tools
por: Blevins, Meridith, et al.
Publicado: (2016)

Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort
por: Carriquiry, Gabriela, et al.
Publicado: (2018)

475. Describing the impact of the COVID-19 pandemic on HIV care in Latin America
por: Person, Anna K, et al.
Publicado: (2020)

Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean
por: Carriquiry, Gabriela, et al.
Publicado: (2015)

Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions?
por: Caro-Vega, Yanink, et al.
Publicado: (2013)

Characterization of data-driven geriatric syndrome clusters in older people with HIV: a Mexican multicenter cross-sectional study
por: Hernandez-Ruiz, Virgilio, et al.
Publicado: (2023)

The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data
por: Giganti, Mark J., et al.
Publicado: (2019)

Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America
por: Cesar, Carina, et al.
Publicado: (2010)

2270. Frequency of Syphilis Annual Screening Testing, Prevalence of Infection and Re-infection and Associated Characteristics among People Receiving Care for HIV in an HIV/AIDS Care Clinic in Mexico City (2001–2017)
por: Camiro-Zúñiga, Antonio, et al.
Publicado: (2018)

Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial
por: Belaunzarán-Zamudio, Pablo F., et al.
Publicado: (2017)

Timing of HIV diagnosis relative to pregnancy and postpartum HIV care continuum outcomes among Latin American women, 2000 to 2017
por: Yohannes, Nathaniel T, et al.
Publicado: (2021)

Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America
por: Coelho, Lara E., et al.
Publicado: (2022)

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America
por: Caro-Vega, Yanink, et al.
Publicado: (2018)

Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model
por: Caro-Vega, Yanink, et al.
Publicado: (2015)

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America
por: Cesar, Carina, et al.
Publicado: (2016)

1120. Impact of Training Residents to Improve HIV Screening in a Teaching Hospital in Mexico City
por: Guerrero-Torres, Lorena, et al.
Publicado: (2020)

High prevalent human papillomavirus infections of the oral cavity of asymptomatic HIV-positive men
por: Méndez-Martínez, Rocío, et al.
Publicado: (2020)

Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men
por: Méndez-Martínez, Rocío, et al.
Publicado: (2014)

The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention
por: Luz, Paula M., et al.
Publicado: (2019)

Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico
por: Marfil-Garza, Braulio A., et al.
Publicado: (2018)

Diagnostic precision of local and World Health Organization definitions of symptomatic COVID-19 cases: an analysis of Mexico's capital
por: Núñez, I., et al.
Publicado: (2022)

Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City
por: Dávila-Conn, Vanessa, et al.
Publicado: (2022)

A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol
por: Fragoso-Saavedra, Sergio, et al.
Publicado: (2020)

Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico
por: Belaunzarán-Zamudio, Pablo F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_is0tkndlcem5jjb7eqtde4dd12